Post-IPO Equity Companies in Cambridge

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Cypherpunk is a biopharmaceutical company developing antibody therapies for cancer while executing a digital-asset treasury strategy.

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.